![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Hannan Anthony J
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.9, Iss.4, 2005-08, pp. : 639-650
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neuroprotection in Huntington;s Disease
Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phosphodiesterases as Therapeutic Targets for Huntington’s Disease
Current Pharmaceutical Design, Vol. 21, Iss. 3, 2015-01 ,pp. :